Month: September 2025

LEXINGTON, Mass. and AMSTERDAM, Sept. 25, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the pricing of its previously announced underwritten public offering of 5,789,473 ordinary shares at a public offering price of $47.50 per share, and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase 526,316 of its ordinary shares at the public offering price per share less the $0.0001 per share exercise price of each pre-funded warrant. The aggregate gross proceeds to uniQure from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by uniQure, are expected to be approximately $300 million. All securities to be sold in the offering...

In June, Faraday Future also signed a deposit agreement with Pinnacle Real Estate Group for the FX Super One, a first class EAI-MPV.Faraday Future Announces Pinnacle Real Estate Group President Calvin Gong as the Next user of an FF 91 2.0, with the Official Delivery Scheduled for October 8Faraday Future Announces Pinnacle Real Estate Group President Calvin Gong as the Next user of an FF 91 2.0, with the Official Delivery Scheduled for October 8LOS ANGELES, Sept. 25, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, announced today that it will deliver the Company’s next FF 91 2.0 Futurist Alliance vehicle on October 8, 2025, to Calvin Gong, President of Pinnacle Real Estate...

Designed in partnership with Xbox, these exceptional gaming handhelds offer incredible gen-on-gen performance gains KEY POINTSOrder now: Pre-orders for ROG Xbox Ally X and ROG Xbox Ally start at 8:00 p.m. ET on September 25, 2025, in select regions Serious gen-on-gen performance: AMD Ryzen™ AI Z2 Extreme and Z2 A processors offer exceptional gaming experiences and battery life improvementsTORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) — ASUS Republic of Gamers (ROG) today announced that pre-orders for the new ROG Xbox Ally and ROG Xbox Ally X handheld gaming console devices will begin in select markets at 8 p.m. ET (5 p.m. PT) on September 25, 2025, with pre-orders in other markets coming soon. Developed in partnership with Xbox, the ROG Xbox Ally and ROG Xbox Ally X offer exceptional ergonomics, a full-screen experience,...

MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) strongly refutes the misleading and inaccurate claims contained in the short-seller report. The report contains numerous inaccuracies and mischaracterizations, including about Aya’s current management team, operations, and resource base, which the Corporation believes are intentionally misleading and are intended to benefit the short seller, which has itself disclosed that it stands to profit in the event that the Corporation’s share price declines, at the expense of Aya shareholders. Key Facts Reliability of Resource Model Confirmed by Silver Ounces Mined since 2021Since 2020, Aya has produced over 10 million ounces (“Moz”) of silver (“Ag”), with mined ounces consistently reconciling against the published...

Vancouver, B.C., Sept. 25, 2025 (GLOBE NEWSWIRE) — NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is pleased to announce, further to its news release of September 24, 2025, that the proposed expansion of its business into the digital asset ecosystem and the implementation of a cryptocurrency treasury management strategy (the “Change of Business”) has been approved by a majority of the Company’s shareholders by written consent resolutions.  The Company has also received final approval from the Canadian Securities Exchange (the “CSE”) for the Change of Business. In connection with the Change of Business, the Company has filed a CSE Form 2A – Listing Statement dated September 24, 2025 (the...

Dubai, United Arab Emirates, Sept. 25, 2025 (GLOBE NEWSWIRE) — Lytus Technologies Holdings PTV. Ltd. (OTCQB: LYTHF) (the “Company”), a leader in platform services and next-generation technology, today announced that it intends to effect a reverse stock split of the Company’s common shares at a ratio of 1-for-2,500. The reverse stock split affects all shareholders uniformly and will not alter the relative rights or percentage interest of shareholders in the Company, except as a result of any fractional shares held, as described below. The Company intends for the reverse stock split to become effective and to begin trading on a split-adjusted basis on the OTCQB at the open of trading on September 26, 2025, under the existing trading symbol “LYTHF”. The new CUSIP number for the common shares following the reverse stock split will...

Palsonify PillsPalsonify pillsPalsonify LogoPalsonify tabletsCrinetics ExteriorCrinetics headquarters in San Diego, CANovel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rapid, durable, and consistent biochemical control and reduced symptom burden Launch of lead product PALSONIFY marks a pivotal milestone for Crinetics as the premier endocrine-focused global pharmaceutical company Investor call to be held today at 6:00 pm ET SAN DIEGO, Sept. 25, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) approved PALSONIFYTM...

Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States EssilorLuxottica’s lens is clinically proven to slow myopia progression in children1,2 Paris, France (25 September 2025) – EssilorLuxottica today announced the U.S. Food and Drug Administration (FDA) has granted market authorization for its Essilor Stellest lens using the De Novo pathway. This follows the product’s earlier recognition with the FDA granting designation as a Breakthrough Device in 2021. The Essilor Stellest lens is the first-ever FDA market authorized spectacle lens clinically proven to slow myopia progression in children1,2. The effectiveness of the Essilor Stellest lens is evidenced by clinical data showing that the lens slowed down myopia progression by 71% on average over two years1,2. Leading the global effort to address...

Issues Notice of Redemption for Secured Notes due 2028 LITTLE ROCK, Ark., Sept. 25, 2025 (GLOBE NEWSWIRE) — Uniti Group Inc. (the “Company,” “Uniti,” or “we”) (Nasdaq: UNIT) today announced that its subsidiary, Windstream Services, LLC (the “Issuer”), has priced its offering (the “Offering”) of $1.4 billion aggregate principal amount of 7.50% Senior Secured Notes due 2033 (the “Notes”). The offering was upsized by $500.0 million aggregate principal amount compared to the previously announced offering size of $900.0 million. The Notes will be issued at an issue price of 100.00%. The Notes will be guaranteed on a senior unsecured basis by the Company and Uniti Group LLC and on a senior secured basis by each of the Issuer’s subsidiaries that guarantees indebtedness under the Company’s senior secured credit facilities and the Company’s...

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 25, 2025 (GLOBE NEWSWIRE) — G2 Goldfields Inc. (“G2” or the “Company”) (TSX:GTWO; OTCQX:GUYGF) is pleased to announce that it has completed the non-brokered private placement announced by the Company on September 11, 2025 (the “Offering”). The Offering consisted of 15,000,000 common shares of the Company (the “Shares”) at a price of C$3.30 per Share, for aggregate gross proceeds of C$49,500,000. The net proceeds from the Offering are expected to be used for continued exploration and development of the Company’s mineral properties in Guyana and for general working capital and general corporate purposes. The Shares have not been and will not be registered under the United States Securities Act of 1933 (the “1933 Act”) and may not...